Burns J W & CO Inc Gsk PLC Transaction History

Burns J W & CO Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Oct 11, 2019	SELL	$40.46 - $43.52 $374,861 - $403,212	-9,265 Closed	0 $0
Q2 2019 Jul 09, 2019	SELL	$39.4 - $42.7 $68,083 - $73,785	-1,728 Reduced 15.72%	9,265 $371,000
Q1 2019 Apr 02, 2019	SELL	$38.57 - $42.69 $7,328 - $8,111	-190 Reduced 1.7%	10,993 $459,000
Q4 2018 Jan 16, 2019	SELL	$37.8 - $42.69 $18,900 - $21,345	-500 Reduced 4.28%	11,183 $427,000
Q3 2018 Oct 05, 2018	SELL	$39.75 - $42.69 $13,276 - $14,258	-334 Reduced 2.78%	11,683 $469,000
Q2 2018 Jul 20, 2018	SELL	$39.61 - $42.76 $54,978 - $59,350	-1,388 Reduced 10.35%	12,017 $484,000
Q1 2018 Apr 04, 2018	SELL	$36.18 - $40.15 $207,058 - $229,778	-5,723 Reduced 29.92%	13,405 $524,000
Q4 2017 Jan 17, 2018	SELL	$35.34 - $41.9 $81,352 - $96,453	-2,302 Reduced 10.74%	19,128 $678,000
Q3 2017 Oct 10, 2017	BUY	$39.44 - $41.55 $845,199 - $890,416	21,430	21,430 $870,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Burns J W & CO Inc, based on Form 13F filings with the SEC.

Stay updated on Burns J W & CO Inc with notifications on news.